Choshi, Japan

Kosuke Nakagawara

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Yamasa Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kosuke Nakagawara. Retrieved from https://idiyas.com/inventor/kosuke-nakagawara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kosuke Nakagawara: Innovator in Muscle-Building and Mitochondria Activation

Introduction

Kosuke Nakagawara is an inventor based in Choshi-shi, Japan. He is known for his innovative work in the field of muscle-building and mitochondria activation. Although he currently holds no granted patents, his contributions to the scientific community are noteworthy.

Latest Patent Applications

Kosuke Nakagawara has filed several patent applications that focus on enhancing muscle health and function. His latest applications include:

1. **PGC-1alpha EXPRESSION PROMOTING AGENT, MUSCLE-BUILDING AGENT AND MITOCHONDRIA ACTIVATING AGENT** - This invention relates to a PGC-1α expression promoting agent, a muscle-building agent, or a mitochondria activating agent, which comprises at least one pyrimidine nucleotide or a precursor thereof as an active ingredient.

2. **MUSCULAR ATROPHY INHIBITOR AND METHOD FOR INHIBITING MUSCULAR ATROPHY** - This application describes a muscular atrophy inhibitor comprising at least one pyrimidine nucleotide or a precursor thereof as an active ingredient. It also outlines a method for inhibiting muscular atrophy by administering at least one pyrimidine nucleotide or a precursor thereof.

Conclusion

Kosuke Nakagawara is making strides in the field of muscle health through his innovative patent applications. His focus on pyrimidine nucleotides as active ingredients showcases his commitment to advancing scientific knowledge and potential therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…